切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2019, Vol. 05 ›› Issue (01) : 71 -74. doi: 10.3877/cma.j.issn.2096-1537.2019.01.014

所属专题: 文献

综述

连续血液净化治疗脓毒症合并急性肾损伤的进展
苏军峰1, 林建东1,()   
  1. 1. 350005 福州,福建医科大学附属第一医院重症医学科
  • 收稿日期:2017-02-20 出版日期:2019-02-28
  • 通信作者: 林建东

Progress of continuous blood purification in treatment of sepsis complicated with AKI

Junfeng Su1, Jiandong Lin1,()   

  1. 1. Department of ICU, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China
  • Received:2017-02-20 Published:2019-02-28
  • Corresponding author: Jiandong Lin
  • About author:
    Corresponding author: Lin Jiandong, Email:
引用本文:

苏军峰, 林建东. 连续血液净化治疗脓毒症合并急性肾损伤的进展[J/OL]. 中华重症医学电子杂志, 2019, 05(01): 71-74.

Junfeng Su, Jiandong Lin. Progress of continuous blood purification in treatment of sepsis complicated with AKI[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2019, 05(01): 71-74.

脓毒症(sepsis)是导致重症监护患者死亡的常见原因。脓毒症患者如合并急性肾损伤(AKI),其病死率明显增加。但目前对脓毒症的发生机制尚不明确。近年国内外关于脓毒症治疗的研究证实,连续性肾脏替代治疗(CRRT),又称连续性血液净化(CBP),在脓毒症的治疗中可发挥显著作用,使患者内环境和免疫内稳态机制得到明显改善,遏制了一系列严重病理生理紊乱,提高了危重病患者救治的成功率。本文将对CRRT/CBP在脓毒症合并AKI中的临床疗效和研究进展作一综述。

Sepsis is the most common cause of death among critically ill patients. The mortality will increase significantly if sepsis patients combine with acute kidney injury. However, the mechanism of sepsis development remains unclear nowadays. Both domestic and international researches on the sepsis management showed that continuous renal replacement therapy (CRRT), also known as continuous blood purification (CBP), plays a significant role in the treatment of sepsis. CRRT can improve the patients′ internal environment and immune homeostasis, inhibit a series of fundamental pathophysiological disorders, and increase the success rate of therapy. We will talk about the clinical efficacy and research progress of CRRT/CBP in patients with sepsis combined with AKI in this review.

1
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 762-774.
2
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
3
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
4
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 [J]. Crit Care Med, 2017, 45(3): 486-552.
5
Holt BG, White JJ, Kuthiala A, et al. Sustained low-efficiency daily dialysis with hemofiltration for acute kidney injury in the presence of sepsis [J]. Clin Nephrol, 2008, 69(1): 40-46.
6
House AA, Ronco C. Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury [J]. Blood Purif, 2008, 26(1): 30-35.
7
邹晓荣. 连续性血液净化治疗脓毒症的临床疗效及机制研究 [J]. 海南医学, 2015, 26(1): 79-81.
8
Ronco C, Ricci Z, De Backer D, et al. Renal replacement therapy in acute kidney injury: controversy and consensus [J]. Crit Care, 2015, 19: 146.
9
Peng Q, Zhang L, Ai Y, et al. Epidemiology of acute kidney injury in intensive care septic patients based on the KDIGO guidelines [J]. Chin Med J, 2014, 127(10): 1820-1826.
10
徐大民, 杨莉. 脓毒症相关急性肾损伤 [J]. 中国实用内科杂志, 2016, 36(06): 441-444.
11
Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey [J]. Lancet, 2015, 386(10002): 1465-1471.
12
李清初. 脓毒血症急性肾损伤的发病机制研究进展 [J]. 华夏医学, 2013, 26(4): 879-882.
13
Zarbock A, Gomez H, Kellum JA. Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies [J]. Curr Opin Crit Care, 2014, 20(6): 588-595.
14
Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury: A narrative review [J]. J Crit Care, 2016, 31(1): 82-89.
15
Kramer P, Wigger W, Rieger J, et al. [Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics] [J]. Klin Wochenschr, 1977, 55(22): 1121-1122.
16
Cho KC, Himmelfarb J, Paganini E, et al. Survival by dialysis modality in critically ill patients with acute kidney injury [J]. J Am Soc Nephrol, 2006, 17(11): 3132-3138.
17
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial [J]. Lancet, 2000, 355(9223): 26-30.
18
吕先念, 刘辉, 周飞虎. 连续性血液净化治疗重症脓毒症疗效分析 [J]. 解放军医学院学报, 2014, 35(11): 1090-1092, 1100.
19
占成业, 万磊, 罗金龙, 等. 连续血液净化治疗严重脓毒症的疗效及免疫调节机制分析 [J]. 临床急诊杂志, 2016, 17(7): 546-549.
20
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury [J]. Nephron Clin Pract, 2012, 120(4): 179-184.
21
中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014) [J]. 中华内科杂志, 2015, 54(6): 557-581.
22
Payen D, Mateo J, Cavaillon JM, et al. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial [J]. Crit Care Med, 2009, 37(3): 803-810.
23
Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury [J]. Clin J Am Soc Nephrol, 2006, 1(5): 915-919.
24
Jun M, Bellomo R, Cass A, et al. Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study [J]. Crit Care Med, 2014, 42(8): 1756-1765.
25
Cole L, Bellomo R, Hart G, et al. A phase Ⅱ randomized, controlled trial of continuous hemofiltration in sepsis [J]. Crit Care Med, 2002, 30(1): 100-106.
26
Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit [J]. N Engl J Med, 2016, 375(2): 122-133.
27
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN Randomized Clinical Trial [J]. JAMA, 2016, 315(20): 2190-2199.
28
Mehta RL. Critical care nephrology in 2016: Managing organ dysfunction in critical care [J]. Nat Rev Nephrol, 2017, 13(2): 71-72.
29
Barbar SD, Binquet C, Monchi M, et al. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial [J]. Trials, 2014, 15: 270.
30
Wald R, Adhikari NK, Smith OM, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury [J]. Kidney Int, 2015, 88(4): 897-904.
31
Palevsky PM, Zhang JH, O′Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury [J]. N Engl J Med, 2008, 359(1): 7-20.
32
Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients [J]. N Engl J Med, 2009, 361(17): 1627-1638.
[1] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[2] 张锦丽, 席毛毛, 褚志刚, 栾夏刚, 陈诺, 王德运, 谢卫国. 大面积烧伤患者发生早期急性肾损伤的危险因素分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 282-287.
[3] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[4] 郭俊楠, 林惠, 任艺林, 乔晞. 氨基酸代谢异常在急性肾损伤向慢性肾脏病转变中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 283-287.
[5] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[6] 邱英鹏, 李欣雨, 邱海波, 刘松桥, 张凌, 于湘友, 秦秉玉, 蒲莹莹, 赵佳钰, 刘永军, 肖月, 杨毅. 连续性肾脏替代治疗质量控制指标体系的建立及验证[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 351-357.
[7] 向阳, 史黎炜, 肖月, 邱海波, 杨毅, 刘松桥, 邱英鹏, 张莹. 连续性肾脏替代治疗在我国五地区重症医学科的效率分析[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 358-363.
[8] 赵佳钰, 邱英鹏, 刘松桥, 杨毅, 张凌, 于湘友, 秦秉玉, 邱海波, 史黎炜, 刘克军, 蒲莹莹, 陈子扬, 赵羽西, 刘永军, 肖月. 连续性肾脏替代治疗在我国五地区重症医学科的应用现况[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 364-374.
[9] 陈曦, 吴宗盛, 郑明珠, 邱海波. 胸腺萎缩在脓毒症免疫紊乱中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 379-383.
[10] 杨翔, 郭兰骐, 谢剑锋, 邱海波. 转录组学在脓毒症诊疗中的临床研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 384-388.
[11] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[12] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[13] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要